Humacyte receives DoD funding for bioengineered blood vessel procurement

Go back to Humacyte receives DoD funding for bioengineered blood vessel procurement
(NASDAQ: HUMA) Delayed: 0.57 -0.03 (5%)
Previous Close $0.60    52 Week High
Open $0.60    52 Week Low
Day High $0.60    P/E N/A 
Day Low $0.57    EPS
Volume 16,534,608